ArticleThe oncologist2021

A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma.

Vikram Pothuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.